nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—Doxylamine—Tamoxifen—pancreatic cancer	0.11	0.213	CrCrCtD
Carbinoxamine—Tripelennamine—Tamoxifen—pancreatic cancer	0.0997	0.193	CrCrCtD
Carbinoxamine—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0932	0.18	CrCrCtD
Carbinoxamine—Clofedanol—Tamoxifen—pancreatic cancer	0.0757	0.146	CrCrCtD
Carbinoxamine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0733	0.142	CrCrCtD
Carbinoxamine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0651	0.126	CrCrCtD
Carbinoxamine—CYP2E1—Dacarbazine—pancreatic cancer	0.0536	0.123	CbGbCtD
Carbinoxamine—CYP2E1—Tamoxifen—pancreatic cancer	0.0427	0.0978	CbGbCtD
Carbinoxamine—CYP2B6—Tamoxifen—pancreatic cancer	0.0421	0.0965	CbGbCtD
Carbinoxamine—CYP2B6—Irinotecan—pancreatic cancer	0.0323	0.0741	CbGbCtD
Carbinoxamine—CYP2C8—Tamoxifen—pancreatic cancer	0.0319	0.0731	CbGbCtD
Carbinoxamine—CYP2C8—Erlotinib—pancreatic cancer	0.0271	0.0621	CbGbCtD
Carbinoxamine—CYP2C19—Tamoxifen—pancreatic cancer	0.0267	0.0613	CbGbCtD
Carbinoxamine—CYP2C8—Fluorouracil—pancreatic cancer	0.0235	0.0539	CbGbCtD
Carbinoxamine—CYP2C9—Tamoxifen—pancreatic cancer	0.0222	0.051	CbGbCtD
Carbinoxamine—CYP2D6—Tamoxifen—pancreatic cancer	0.0203	0.0466	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—pancreatic cancer	0.0177	0.0405	CbGbCtD
Carbinoxamine—CYP2D6—Erlotinib—pancreatic cancer	0.0173	0.0396	CbGbCtD
Carbinoxamine—CYP2C9—Fluorouracil—pancreatic cancer	0.0164	0.0376	CbGbCtD
Carbinoxamine—CYP3A4—Tamoxifen—pancreatic cancer	0.0129	0.0296	CbGbCtD
Carbinoxamine—CYP3A4—Erlotinib—pancreatic cancer	0.011	0.0252	CbGbCtD
Carbinoxamine—CYP3A4—Irinotecan—pancreatic cancer	0.00993	0.0228	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—pancreatic cancer	0.00853	0.0196	CbGbCtD
Carbinoxamine—CYP3A4—Docetaxel—pancreatic cancer	0.00727	0.0167	CbGbCtD
Carbinoxamine—CYP3A4—Sunitinib—pancreatic cancer	0.00724	0.0166	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—pancreatic cancer	0.00542	0.0124	CbGbCtD
Carbinoxamine—Chest tightness—Docetaxel—pancreatic cancer	0.00101	0.0216	CcSEcCtD
Carbinoxamine—Neuritis—Gemcitabine—pancreatic cancer	0.000894	0.0191	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.000773	0.0165	CcSEcCtD
Carbinoxamine—Nasal congestion—Sunitinib—pancreatic cancer	0.000663	0.0142	CcSEcCtD
Carbinoxamine—Neuritis—Docetaxel—pancreatic cancer	0.000635	0.0136	CcSEcCtD
Carbinoxamine—Euphoric mood—Fluorouracil—pancreatic cancer	0.000564	0.0121	CcSEcCtD
Carbinoxamine—Photosensitivity—Fluorouracil—pancreatic cancer	0.000543	0.0116	CcSEcCtD
Carbinoxamine—Chest discomfort—Docetaxel—pancreatic cancer	0.000536	0.0115	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.000527	0.0113	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.000456	0.00976	CcSEcCtD
Carbinoxamine—Irritability—Fluorouracil—pancreatic cancer	0.000455	0.00973	CcSEcCtD
Carbinoxamine—Chills—Erlotinib—pancreatic cancer	0.000433	0.00927	CcSEcCtD
Carbinoxamine—Neuritis—Epirubicin—pancreatic cancer	0.000428	0.00916	CcSEcCtD
Carbinoxamine—Sweating increased—Irinotecan—pancreatic cancer	0.000419	0.00896	CcSEcCtD
Carbinoxamine—Neuritis—Doxorubicin—pancreatic cancer	0.000396	0.00847	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000376	0.00804	CcSEcCtD
Carbinoxamine—Chills—Sunitinib—pancreatic cancer	0.000375	0.00802	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000366	0.00783	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00036	0.0077	CcSEcCtD
Carbinoxamine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000349	0.00746	CcSEcCtD
Carbinoxamine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000343	0.00733	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000339	0.00726	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000336	0.00718	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000335	0.00717	CcSEcCtD
Carbinoxamine—Anorexia—Tamoxifen—pancreatic cancer	0.00033	0.00707	CcSEcCtD
Carbinoxamine—Anorexia—Erlotinib—pancreatic cancer	0.000327	0.00699	CcSEcCtD
Carbinoxamine—Convulsion—Sunitinib—pancreatic cancer	0.000315	0.00674	CcSEcCtD
Carbinoxamine—Insomnia—Tamoxifen—pancreatic cancer	0.000314	0.00671	CcSEcCtD
Carbinoxamine—Paraesthesia—Tamoxifen—pancreatic cancer	0.000311	0.00666	CcSEcCtD
Carbinoxamine—Insomnia—Erlotinib—pancreatic cancer	0.00031	0.00664	CcSEcCtD
Carbinoxamine—Chills—Irinotecan—pancreatic cancer	0.000309	0.00661	CcSEcCtD
Carbinoxamine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000305	0.00653	CcSEcCtD
Carbinoxamine—Dyspepsia—Erlotinib—pancreatic cancer	0.000302	0.00646	CcSEcCtD
Carbinoxamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000301	0.00645	CcSEcCtD
Carbinoxamine—Chills—Gemcitabine—pancreatic cancer	0.000301	0.00644	CcSEcCtD
Carbinoxamine—Fatigue—Tamoxifen—pancreatic cancer	0.000299	0.00639	CcSEcCtD
Carbinoxamine—Decreased appetite—Erlotinib—pancreatic cancer	0.000298	0.00638	CcSEcCtD
Carbinoxamine—Constipation—Tamoxifen—pancreatic cancer	0.000296	0.00634	CcSEcCtD
Carbinoxamine—Fatigue—Erlotinib—pancreatic cancer	0.000296	0.00633	CcSEcCtD
Carbinoxamine—Constipation—Erlotinib—pancreatic cancer	0.000293	0.00627	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000291	0.00622	CcSEcCtD
Carbinoxamine—Anorexia—Sunitinib—pancreatic cancer	0.000283	0.00605	CcSEcCtD
Carbinoxamine—Urticaria—Tamoxifen—pancreatic cancer	0.000275	0.00589	CcSEcCtD
Carbinoxamine—Vision blurred—Fluorouracil—pancreatic cancer	0.000271	0.00579	CcSEcCtD
Carbinoxamine—Vertigo—Irinotecan—pancreatic cancer	0.000269	0.00576	CcSEcCtD
Carbinoxamine—Insomnia—Sunitinib—pancreatic cancer	0.000269	0.00574	CcSEcCtD
Carbinoxamine—Paraesthesia—Sunitinib—pancreatic cancer	0.000267	0.0057	CcSEcCtD
Carbinoxamine—Photosensitivity—Epirubicin—pancreatic cancer	0.000264	0.00565	CcSEcCtD
Carbinoxamine—Dyspepsia—Sunitinib—pancreatic cancer	0.000261	0.00559	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00026	0.00556	CcSEcCtD
Carbinoxamine—Decreased appetite—Sunitinib—pancreatic cancer	0.000258	0.00552	CcSEcCtD
Carbinoxamine—Fatigue—Sunitinib—pancreatic cancer	0.000256	0.00548	CcSEcCtD
Carbinoxamine—Constipation—Sunitinib—pancreatic cancer	0.000254	0.00543	CcSEcCtD
Carbinoxamine—Asthenia—Tamoxifen—pancreatic cancer	0.000249	0.00532	CcSEcCtD
Carbinoxamine—Convulsion—Fluorouracil—pancreatic cancer	0.000249	0.00532	CcSEcCtD
Carbinoxamine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000247	0.00529	CcSEcCtD
Carbinoxamine—Confusional state—Irinotecan—pancreatic cancer	0.000247	0.00527	CcSEcCtD
Carbinoxamine—Asthenia—Erlotinib—pancreatic cancer	0.000246	0.00526	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000245	0.00523	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000239	0.00512	CcSEcCtD
Carbinoxamine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000237	0.00507	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000236	0.00506	CcSEcCtD
Carbinoxamine—Confusional state—Fluorouracil—pancreatic cancer	0.000236	0.00505	CcSEcCtD
Carbinoxamine—Diarrhoea—Erlotinib—pancreatic cancer	0.000235	0.00502	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000233	0.00499	CcSEcCtD
Carbinoxamine—Anorexia—Irinotecan—pancreatic cancer	0.000233	0.00499	CcSEcCtD
Carbinoxamine—Diplopia—Epirubicin—pancreatic cancer	0.000232	0.00496	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00023	0.00493	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000229	0.00491	CcSEcCtD
Carbinoxamine—Dizziness—Tamoxifen—pancreatic cancer	0.000229	0.0049	CcSEcCtD
Carbinoxamine—Tachycardia—Fluorouracil—pancreatic cancer	0.000229	0.00489	CcSEcCtD
Carbinoxamine—Hypotension—Irinotecan—pancreatic cancer	0.000229	0.00489	CcSEcCtD
Carbinoxamine—Anorexia—Gemcitabine—pancreatic cancer	0.000227	0.00486	CcSEcCtD
Carbinoxamine—Dizziness—Erlotinib—pancreatic cancer	0.000227	0.00485	CcSEcCtD
Carbinoxamine—Anorexia—Fluorouracil—pancreatic cancer	0.000223	0.00478	CcSEcCtD
Carbinoxamine—Hypotension—Gemcitabine—pancreatic cancer	0.000223	0.00476	CcSEcCtD
Carbinoxamine—Insomnia—Irinotecan—pancreatic cancer	0.000221	0.00473	CcSEcCtD
Carbinoxamine—Vomiting—Tamoxifen—pancreatic cancer	0.00022	0.00471	CcSEcCtD
Carbinoxamine—Paraesthesia—Irinotecan—pancreatic cancer	0.00022	0.0047	CcSEcCtD
Carbinoxamine—Hypotension—Fluorouracil—pancreatic cancer	0.000219	0.00468	CcSEcCtD
Carbinoxamine—Vomiting—Erlotinib—pancreatic cancer	0.000218	0.00466	CcSEcCtD
Carbinoxamine—Somnolence—Irinotecan—pancreatic cancer	0.000217	0.00465	CcSEcCtD
Carbinoxamine—Headache—Tamoxifen—pancreatic cancer	0.000217	0.00465	CcSEcCtD
Carbinoxamine—Insomnia—Gemcitabine—pancreatic cancer	0.000215	0.00461	CcSEcCtD
Carbinoxamine—Dyspepsia—Irinotecan—pancreatic cancer	0.000215	0.00461	CcSEcCtD
Carbinoxamine—Headache—Erlotinib—pancreatic cancer	0.000215	0.0046	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—pancreatic cancer	0.000215	0.00459	CcSEcCtD
Carbinoxamine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000214	0.00458	CcSEcCtD
Carbinoxamine—Chills—Docetaxel—pancreatic cancer	0.000214	0.00457	CcSEcCtD
Carbinoxamine—Asthenia—Sunitinib—pancreatic cancer	0.000213	0.00456	CcSEcCtD
Carbinoxamine—Decreased appetite—Irinotecan—pancreatic cancer	0.000213	0.00455	CcSEcCtD
Carbinoxamine—Insomnia—Fluorouracil—pancreatic cancer	0.000212	0.00453	CcSEcCtD
Carbinoxamine—Somnolence—Gemcitabine—pancreatic cancer	0.000212	0.00453	CcSEcCtD
Carbinoxamine—Fatigue—Irinotecan—pancreatic cancer	0.000211	0.00451	CcSEcCtD
Carbinoxamine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00021	0.0045	CcSEcCtD
Carbinoxamine—Constipation—Irinotecan—pancreatic cancer	0.000209	0.00447	CcSEcCtD
Carbinoxamine—Somnolence—Fluorouracil—pancreatic cancer	0.000208	0.00445	CcSEcCtD
Carbinoxamine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000207	0.00443	CcSEcCtD
Carbinoxamine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000206	0.00441	CcSEcCtD
Carbinoxamine—Nausea—Tamoxifen—pancreatic cancer	0.000206	0.0044	CcSEcCtD
Carbinoxamine—Fatigue—Gemcitabine—pancreatic cancer	0.000205	0.00439	CcSEcCtD
Carbinoxamine—Constipation—Gemcitabine—pancreatic cancer	0.000204	0.00436	CcSEcCtD
Carbinoxamine—Nausea—Erlotinib—pancreatic cancer	0.000204	0.00436	CcSEcCtD
Carbinoxamine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000204	0.00436	CcSEcCtD
Carbinoxamine—Diarrhoea—Sunitinib—pancreatic cancer	0.000203	0.00435	CcSEcCtD
Carbinoxamine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000202	0.00431	CcSEcCtD
Carbinoxamine—Dizziness—Sunitinib—pancreatic cancer	0.000196	0.0042	CcSEcCtD
Carbinoxamine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000196	0.0042	CcSEcCtD
Carbinoxamine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000193	0.00413	CcSEcCtD
Carbinoxamine—Vomiting—Sunitinib—pancreatic cancer	0.000189	0.00404	CcSEcCtD
Carbinoxamine—Urticaria—Fluorouracil—pancreatic cancer	0.000186	0.00398	CcSEcCtD
Carbinoxamine—Headache—Sunitinib—pancreatic cancer	0.000186	0.00398	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—pancreatic cancer	0.000185	0.00396	CcSEcCtD
Carbinoxamine—Palpitations—Docetaxel—pancreatic cancer	0.000183	0.00392	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000183	0.00392	CcSEcCtD
Carbinoxamine—Convulsion—Docetaxel—pancreatic cancer	0.000179	0.00384	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—pancreatic cancer	0.000179	0.00382	CcSEcCtD
Carbinoxamine—Nausea—Sunitinib—pancreatic cancer	0.000176	0.00377	CcSEcCtD
Carbinoxamine—Asthenia—Irinotecan—pancreatic cancer	0.000175	0.00375	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000175	0.00375	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000171	0.00367	CcSEcCtD
Carbinoxamine—Asthenia—Gemcitabine—pancreatic cancer	0.000171	0.00366	CcSEcCtD
Carbinoxamine—Confusional state—Docetaxel—pancreatic cancer	0.00017	0.00365	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000169	0.00362	CcSEcCtD
Carbinoxamine—Diarrhoea—Irinotecan—pancreatic cancer	0.000167	0.00358	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000167	0.00357	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000166	0.00354	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—pancreatic cancer	0.000165	0.00354	CcSEcCtD
Carbinoxamine—Tachycardia—Docetaxel—pancreatic cancer	0.000165	0.00353	CcSEcCtD
Carbinoxamine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000163	0.00349	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000162	0.00347	CcSEcCtD
Carbinoxamine—Dizziness—Irinotecan—pancreatic cancer	0.000162	0.00346	CcSEcCtD
Carbinoxamine—Anorexia—Docetaxel—pancreatic cancer	0.000161	0.00345	CcSEcCtD
Carbinoxamine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00016	0.00343	CcSEcCtD
Carbinoxamine—Hypotension—Docetaxel—pancreatic cancer	0.000158	0.00338	CcSEcCtD
Carbinoxamine—Vomiting—Irinotecan—pancreatic cancer	0.000156	0.00333	CcSEcCtD
Carbinoxamine—Dizziness—Fluorouracil—pancreatic cancer	0.000155	0.00331	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000154	0.0033	CcSEcCtD
Carbinoxamine—Headache—Irinotecan—pancreatic cancer	0.000153	0.00328	CcSEcCtD
Carbinoxamine—Insomnia—Docetaxel—pancreatic cancer	0.000153	0.00327	CcSEcCtD
Carbinoxamine—Paraesthesia—Docetaxel—pancreatic cancer	0.000152	0.00325	CcSEcCtD
Carbinoxamine—Vomiting—Gemcitabine—pancreatic cancer	0.000151	0.00324	CcSEcCtD
Carbinoxamine—Somnolence—Docetaxel—pancreatic cancer	0.00015	0.00321	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—pancreatic cancer	0.00015	0.0032	CcSEcCtD
Carbinoxamine—Headache—Gemcitabine—pancreatic cancer	0.000149	0.00319	CcSEcCtD
Carbinoxamine—Vomiting—Fluorouracil—pancreatic cancer	0.000149	0.00319	CcSEcCtD
Carbinoxamine—Dyspepsia—Docetaxel—pancreatic cancer	0.000149	0.00318	CcSEcCtD
Carbinoxamine—Decreased appetite—Docetaxel—pancreatic cancer	0.000147	0.00314	CcSEcCtD
Carbinoxamine—Headache—Fluorouracil—pancreatic cancer	0.000147	0.00314	CcSEcCtD
Carbinoxamine—Fatigue—Docetaxel—pancreatic cancer	0.000146	0.00312	CcSEcCtD
Carbinoxamine—Nausea—Irinotecan—pancreatic cancer	0.000145	0.00311	CcSEcCtD
Carbinoxamine—Constipation—Docetaxel—pancreatic cancer	0.000145	0.00309	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—pancreatic cancer	0.000144	0.00308	CcSEcCtD
Carbinoxamine—Nausea—Gemcitabine—pancreatic cancer	0.000142	0.00303	CcSEcCtD
Carbinoxamine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000139	0.00298	CcSEcCtD
Carbinoxamine—Nausea—Fluorouracil—pancreatic cancer	0.000139	0.00298	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—pancreatic cancer	0.000138	0.00296	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—pancreatic cancer	0.000137	0.00293	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—pancreatic cancer	0.000136	0.0029	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—pancreatic cancer	0.000133	0.00285	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—pancreatic cancer	0.000132	0.00282	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—pancreatic cancer	0.000128	0.00275	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—pancreatic cancer	0.000127	0.00271	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—pancreatic cancer	0.000126	0.00269	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—pancreatic cancer	0.000126	0.00269	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—pancreatic cancer	0.000123	0.00264	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—pancreatic cancer	0.000122	0.00261	CcSEcCtD
Carbinoxamine—Asthenia—Docetaxel—pancreatic cancer	0.000121	0.00259	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—pancreatic cancer	0.000121	0.00259	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—pancreatic cancer	0.000119	0.00254	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—pancreatic cancer	0.000116	0.00248	CcSEcCtD
Carbinoxamine—Diarrhoea—Docetaxel—pancreatic cancer	0.000116	0.00247	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—pancreatic cancer	0.000115	0.00246	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—pancreatic cancer	0.000114	0.00244	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—pancreatic cancer	0.000112	0.0024	CcSEcCtD
Carbinoxamine—Dizziness—Docetaxel—pancreatic cancer	0.000112	0.00239	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000112	0.00239	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—pancreatic cancer	0.000111	0.00238	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00011	0.00236	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—pancreatic cancer	0.000109	0.00233	CcSEcCtD
Carbinoxamine—Vomiting—Docetaxel—pancreatic cancer	0.000108	0.0023	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—pancreatic cancer	0.000107	0.00228	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—pancreatic cancer	0.000106	0.00228	CcSEcCtD
Carbinoxamine—Headache—Docetaxel—pancreatic cancer	0.000106	0.00227	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000103	0.00221	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—pancreatic cancer	0.000103	0.00221	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000103	0.0022	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—pancreatic cancer	0.000102	0.00219	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000102	0.00218	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—pancreatic cancer	0.000101	0.00217	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—pancreatic cancer	0.000101	0.00215	CcSEcCtD
Carbinoxamine—Nausea—Docetaxel—pancreatic cancer	0.0001	0.00215	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—pancreatic cancer	0.0001	0.00215	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—pancreatic cancer	9.91e-05	0.00212	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—pancreatic cancer	9.86e-05	0.00211	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—pancreatic cancer	9.83e-05	0.0021	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—pancreatic cancer	9.75e-05	0.00209	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—pancreatic cancer	9.54e-05	0.00204	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—pancreatic cancer	9.48e-05	0.00203	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—pancreatic cancer	9.4e-05	0.00201	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—pancreatic cancer	9.38e-05	0.00201	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—pancreatic cancer	9.29e-05	0.00199	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—pancreatic cancer	9.17e-05	0.00196	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—pancreatic cancer	9.1e-05	0.00195	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—pancreatic cancer	9.06e-05	0.00194	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—pancreatic cancer	9.02e-05	0.00193	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—pancreatic cancer	8.7e-05	0.00186	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—pancreatic cancer	8.38e-05	0.00179	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—pancreatic cancer	8.18e-05	0.00175	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—pancreatic cancer	7.8e-05	0.00167	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—pancreatic cancer	7.57e-05	0.00162	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—pancreatic cancer	7.54e-05	0.00161	CcSEcCtD
Carbinoxamine—Vomiting—Epirubicin—pancreatic cancer	7.25e-05	0.00155	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—pancreatic cancer	7.22e-05	0.00154	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—pancreatic cancer	7.14e-05	0.00153	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—pancreatic cancer	6.98e-05	0.00149	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—pancreatic cancer	6.77e-05	0.00145	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—pancreatic cancer	6.71e-05	0.00144	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—pancreatic cancer	6.61e-05	0.00141	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—pancreatic cancer	6.27e-05	0.00134	CcSEcCtD
